Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
740 participants
INTERVENTIONAL
2004-05-31
2006-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rebamipide
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be able to sign and date an informed consent
Exclusion Criteria
* glaucoma or ocular hypertension
* using Restasis
* use of topically instilled ocular medications during study
* use of contact lenses
* history of ocular surgery within 12 months
* females who are pregnant, breast feeding, or child-bearing potential and not willing to remain abstinent or use contraception
* presence of Stevens-Johnson syndrome
* any anticipated change in medication through-out study
* concurrent involvement in another study or previous receipt of this drug
* cannot be safely be weaned off of ocular medications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harold Helms, MD
Birmingham, Alabama, United States
Michael Bernstein, MD
Birmingham, Alabama, United States
I Care! Eye Care!
Flagstaff, Arizona, United States
Harvey and Bernice Jones Eye Institute
Little Rock, Arkansas, United States
United Medical Research Institute
Inglewood, California, United States
Benchmark Research
San Francisco, California, United States
Southern California Clinical Research, Inc.
San Marino, California, United States
Colorado Eye Associates, PC
Colorado Springs, Colorado, United States
Danbury Eye Physicians and Surgeons, P.C.
Danbury, Connecticut, United States
Florida Ophthalmic Institute
Gainesville, Florida, United States
Florida Wellcare Alliance, L.C.
Inverness, Florida, United States
Shettle Eye Center
Largo, Florida, United States
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Tukio Institute for Clinical Research
North Miami Beach, Florida, United States
Magnolia Research Group, Inc.
Ocala, Florida, United States
Radiant Research - West Palm Beach
West Palm Beach, Florida, United States
Vision Incorporated
Savannah, Georgia, United States
Welborn Clinic
Evansville, Indiana, United States
Heartland Research Associates, LLC
Wichita, Kansas, United States
Wichita Clinic, PA
Wichita, Kansas, United States
Taustine Eye Center
Louisville, Kentucky, United States
Bossier Optical, Inc.
Bossier City, Louisiana, United States
Stevenson Medical Surgical Eye Center
New Orleans, Louisiana, United States
Family Eye Centers
New Orleans, Louisiana, United States
Ophthalmic Research Associates, Inc.
North Andover, Massachusetts, United States
Minnesota Eye Associates
Minneapolis, Minnesota, United States
Depremont Eye Specialists
Gulfport, Mississippi, United States
Opthalmology Associates
Creve Coeur, Missouri, United States
Clinical Research Laboratories
Piscataway, New Jersey, United States
Ophthalmology Associates
Princeton, New Jersey, United States
Eye Care Associates
Bethpage, New York, United States
Ophthmalmic Consultants of Long Island
Lynbrook, New York, United States
Mt. Sinai Medical Center School of Medicine
New York, New York, United States
Rochester Ophthalmological Group
Rochester, New York, United States
Ophthalmic Consultants of Long Island
Rockville Centre, New York, United States
Ophthalmic Consultants of Long Island
Valley Stream, New York, United States
Western Wake Eye Center, P.A.
Cary, North Carolina, United States
Southeast Clinical Research Associates
Charlotte, North Carolina, United States
Horizon Eye Care - Clinical Research Dept.
Charlotte, North Carolina, United States
Cornerstone Research Care
High Point, North Carolina, United States
Carolina Eye Associates
Southern Pines, North Carolina, United States
Cincinnati Eye Institute
Cincinnati, Ohio, United States
Comprehensive Opthalmology & Optical Services
Cleveland, Ohio, United States
Bend Medical Clinic
Bend, Oregon, United States
Medical Eye Center
Medford, Oregon, United States
Valley Clinical Research Center
Easton, Pennsylvania, United States
Philadelphia Eye Associates
Philadelphia, Pennsylvania, United States
University of Pittsburg Eye and Ear Institute
Pittsburgh, Pennsylvania, United States
Glaucome-Cataract Consultants
Pittsburgh, Pennsylvania, United States
Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
Total Eye Care, P.A.
Memphis, Tennessee, United States
Corona Research Consultants, Inc.
El Paso, Texas, United States
The University of Texas Medical Branch
Galveston, Texas, United States
Physician Research Network
Houston, Texas, United States
Houston, Texas, United States
Medical Center Ophthalmology
Houston, Texas, United States
Houston Eye Associates
Houston, Texas, United States
Sun Research Institute
San Antonio, Texas, United States
Eye Clinic of South Texas
San Antonio, Texas, United States
Advanced Healthcare Clinical Research Center
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37E-03-201
Identifier Type: -
Identifier Source: org_study_id